Brian Niemietz | New York Daily News Online pharmaceutical brands Hims & Hers are introducing a weight-loss drug containing a compounded form of semaglutide, the active ingredient in Ozempic, for a fraction of the price. Both brands, owned by the same company headquartered in San Francisco, plan to provide a one-month supply of the GLP-1 injections for $199. That same dose of Ozempic reportedly retails for nearly $1,000.